04/29/2024 11:15 PM | Acrivon Therapeutics (Filer)
| Form EFFECT | |
04/26/2024 7:30 AM | Acrivon Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 7:30 AM | Acrivon Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 7:33 AM | Acrivon Therapeutics (Filer) Acrivon Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024 7:36 AM | Acrivon Therapeutics (Filer) Acrivon Therapeutics (Filer)
| Form ARS | |
04/17/2024 3:39 PM | Acrivon Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
04/15/2024 7:53 AM | Acrivon Therapeutics (Issuer) EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/15/2024 7:21 AM | Acrivon Therapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
04/11/2024 3:16 PM | Acrivon Therapeutics (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
04/09/2024 6:05 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2024 8:06 AM | Acrivon Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2024 7:00 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 6:36 AM | Acrivon Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/06/2024 3:32 PM | Acrivon Therapeutics (Issuer) Palani Santhosh (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 7:15 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 4:13 PM | Acrivon Therapeutics (Issuer) Masson Kristina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 4:14 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:57 PM | Acrivon Therapeutics (Subject) CITADEL ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 3:36 PM | Acrivon Therapeutics (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 8:51 AM | Acrivon Therapeutics (Subject) Marshall Wace North America L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024 2:40 PM | Acrivon Therapeutics (Subject) Sands Capital Ventures, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 3:37 PM | Acrivon Therapeutics (Issuer) Magovcevic-Liebisch Ivana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 3:34 PM | Acrivon Therapeutics (Issuer) Magovcevic-Liebisch Ivana (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/08/2024 7:27 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/19/2024 3:24 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 3:45 PM | Acrivon Therapeutics (Issuer) Cuillerot Jean-Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 3:46 PM | Acrivon Therapeutics (Issuer) Cuillerot Jean-Marie (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/08/2024 6:28 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/17/2023 11:15 PM | Acrivon Therapeutics (Filer)
| Form EFFECT | |
12/08/2023 3:21 PM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 3:35 PM | Acrivon Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
11/16/2023 6:41 PM | Acrivon Therapeutics (Issuer) Blume-Jensen Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:41 PM | Acrivon Therapeutics (Issuer) Devroe Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:41 PM | Acrivon Therapeutics (Issuer) Gamelin Erick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:42 PM | Acrivon Therapeutics (Issuer) Holm-Jorgensen Rasmus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:42 PM | Acrivon Therapeutics (Issuer) Masson Kristina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 6:43 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2023 8:12 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 7:02 AM | Acrivon Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/19/2023 6:45 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 6:13 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad) You might have seen that Bitcoin was one of the best performing assets of 2023.
It gained 164%.
But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin.
He found something better. Click here to find out that this 8,788% cryptocurrency is. |
09/28/2023 6:17 PM | Acrivon Therapeutics (Issuer) Miller Mary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 4:23 PM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/23/2023 3:19 PM | Acrivon Therapeutics (Issuer) Blume-Jensen Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2023 7:25 AM | Acrivon Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/11/2023 6:11 AM | Acrivon Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/11/2023 6:17 AM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2023 3:58 PM | Acrivon Therapeutics (Issuer) BAUM CHARLES M (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/28/2023 4:06 PM | Acrivon Therapeutics (Issuer) BAUM CHARLES M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 2:47 PM | Acrivon Therapeutics (Issuer) Chione Ltd (Reporting) Czernik Marcin (Reporting) Hadjimichael Andreas (Reporting) Nikolaou Anastasis (Reporting) Smolokowski Wiaczeslaw (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/22/2023 4:02 PM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2023 4:15 PM | Acrivon Therapeutics (Issuer) Chione Ltd (Reporting) Czernik Marcin (Reporting) Hadjimichael Andreas (Reporting) Nikolaou Anastasis (Reporting) Smolokowski Wiaczeslaw (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 4:21 PM | Acrivon Therapeutics (Issuer) Holm-Jorgensen Rasmus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 5:33 PM | Acrivon Therapeutics (Issuer) Chione Ltd (Reporting) Czernik Marcin (Reporting) Hadjimichael Andreas (Reporting) Nikolaou Anastasis (Reporting) Smolokowski Wiaczeslaw (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 11:20 AM | Acrivon Therapeutics (Subject) Chione Ltd (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023 4:01 PM | Acrivon Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/01/2023 7:40 PM | Acrivon Therapeutics (Issuer) Blume-Jensen Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |